Study Examines Warfarin’s Impact on AF to Sinus Rhythm
The results of a recent study that analyzed Warfarin’s impact of restoring sinus rhythm on Warfarin sensitivity has been published on Medscape. The periods examined by researchers included zero to...
Study Seeks VOM’s Role in AF Recurrences after Patients’ Ablations
A new study claims to shed light on the Vein of Marshall (VOM)’s role in AF recurrences after the patients have had an ablation procedure. For this study, which is...
Multaq Still Viewed as Last-ditch Effort in Treating AF
Multaq is an anticoagulant medication that is used as a treatment for atrial fibrillation (AF), which is caused by an irregular heart rhythm or flutter. While the condition is serious,...
AF Prevention Removes Need for Multaq, Other Drugs
There are many prescription anticoagulant medications that can help AF patients control their AF episodes and aid in stroke prevention. But the ideal way to control AF episodes is to...
A Chorus of ‘Not Us’ Heard After Apixaban Approval Delay
After it was announced that the FDA is going to delay approving Apixaban as a stroke prevention medication for AF patients while the agency gains more information, the move has...